## **Core Concept**
ITP (Immune Thrombocytopenic Purpura) is an autoimmune disease characterized by the production of antibodies against specific platelet antigens. This results in the premature destruction of platelets.

## **Why the Correct Answer is Right**
The correct answer, **, refers to the glycoprotein IIb/IIIa complex on the platelet surface. In ITP, autoantibodies are primarily directed against this complex, which is crucial for platelet aggregation. The binding of these autoantibodies to the platelet surface marks the platelets for destruction, primarily in the spleen.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While other platelet glycoproteins can be targets in some cases of ITP, they are not the primary or most commonly associated targets.
- **Option B:** This option does not directly relate to a commonly recognized target in ITP.
- **Option C:** Similarly, this option does not correspond to a primary antigen in ITP.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that ITP is often treated with therapies aimed at reducing antibody production or the destruction of antibody-coated platelets, such as corticosteroids, immunoglobulins, and sometimes splenectomy.

## **Correct Answer:** . GPIb/IX/IIa complex (or more specifically, **GPIaIIa or GPIIb/IIIa).